YC W23Inactive
Lavo Life Sciences
AI for drug formulation
About
Lavo Life Sciences runs simulations of drug molecules on computers. Pharma companies use these simulations to guide their experiments and ultimately save time and money in the lab. This will de-risk and expedite clinical trials and FDA approval.
Founders
- Scott Swarthout
- Zach Glick
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Lavo Life Sciences.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryMachine LearningBiotechDrug discovery